Effect of ChatGPT-Based Digital Counseling on Anxiety and Depression in Cancer: A Randomized Trial

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 2, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
CancerAnxietyDepressionArtifical Intelligence
Interventions
BEHAVIORAL

ChatGPT-Based Digital Counseling

Participants in this group received standard clinician-led chemotherapy education plus access to ChatGPT-based digital counseling. They could submit up to 10 personalized questions regarding their treatment, side effects, and supportive care. Oncology specialists reviewed ChatGPT-generated responses for accuracy. This intervention aimed to assess whether AI-assisted counseling could reduce anxiety and depression levels in newly diagnosed cancer patients.

BEHAVIORAL

Standard Clinician-Led Education

Participants in this group received only standard clinician-led chemotherapy education, delivered by oncology physicians and nurses. The education covered key aspects of chemotherapy, including potential side effects, treatment schedules, and supportive care recommendations. Unlike the ChatGPT group, these participants did not receive AI-assisted counseling or additional interactive educational tools.

Trial Locations (2)

06170

Etlik City Hospital, Ankara

06500

Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara

All Listed Sponsors
lead

Gazi University

OTHER

NCT06854315 - Effect of ChatGPT-Based Digital Counseling on Anxiety and Depression in Cancer: A Randomized Trial | Biotech Hunter | Biotech Hunter